Abstract
We characterized patterns of occurrence and the impact of neratinib-associated diarrhea in the absence of protocol-directed antidiarrheal prophylaxis or a formal diarrhea management plan using data from Extended Adjuvant Treatment of Breast Cancer with Neratinib (ExteNET). ExteNET is a multicenter, double-blind, placebo-controlled, randomized phase III trial involving community-based and academic institutions in 40 countries. Women with HER2-positive early-stage breast cancer with prior standard primary therapy and trastuzumab-based (neo)adjuvant therapy were randomized to neratinib 240 mg/day or placebo for 12 months. Safety, a secondary outcome, was assessed using the National Cancer Institute Common Terminology Criteria version 3.0. Health-related quality of life by diarrhea grade was assessed using Functional Assessment of Cancer Therapy-Breast (FACT-B). Two thousand eight hundred sixteen women (1408 per group) were safety-evaluable. Grade 3 and 4 diarrhea occurred in 561 (39.8%) and 1 (0.1%) patients with neratinib versus 23 (1.6%) and 0 patients with placebo, respectively. In the neratinib group, 28.6% of patients had grade 3 events during month 1 decreasing to ≤ 6% after month 3. The median cumulative duration of grade 3...Continue Reading
References
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J BradyG Shiomoto
Jul 8, 2000·The Oncologist·R B ArbuckleC Zacker
Jun 18, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joyce O'ShaughnessyRobert Leonard
Oct 27, 2004·Journal of Clinical Epidemiology·David T EtonWilliam C Wood
Jul 30, 2005·Cancer Letters·Sridhar K Rabindran
Dec 29, 2006·The New England Journal of Medicine·Charles E GeyerDavid Cameron
Jan 22, 2008·Breast Cancer Research and Treatment·John P CrownSteve Chan
Apr 16, 2008·Journal of Pain and Symptom Management·Nathan I Cherny
Mar 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwok-K WongHoward A Burris
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinRajendra Badwe
Aug 21, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Miguel MartinAhmad Awada
Jul 25, 2014·Cancer Chemotherapy and Pharmacology·Dorothy M KeefeStephen T Sonis
Sep 5, 2014·The Lancet Oncology·Jervoise AndreyevDavid Ferry
Mar 11, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S-E Al-BatranUNKNOWN Arbeitsgemeinschaft Internistische Onkologie (AIO)
Feb 15, 2016·The Lancet Oncology·Arlene ChanUNKNOWN ExteNET Study Group
Apr 15, 2016·JAMA Oncology·Ahmad AwadaLisa A Carey
Jan 7, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S M SwainJ Baselga
Jun 6, 2017·The New England Journal of Medicine·Gunter von MinckwitzUNKNOWN APHINITY Steering Committee and Investigators
Nov 18, 2017·The Lancet Oncology·Miguel MartinUNKNOWN ExteNET Study Group
Feb 9, 2018·Nature·David M HymanDavid B Solit
Jan 29, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DelalogeM Martin
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DelalogeM Martin
Jun 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S-E Al-BatranC Pauligk
Citations
Jan 24, 2019·Breast Cancer Research and Treatment·Hope S RugoLinda Bosserman
May 28, 2020·Future Oncology·Yolanda JerezIsabel Echavarría
Sep 10, 2020·Scientific Reports·Yong Joo ParkSeulki Lee
Jul 29, 2020·Breast Cancer Research and Treatment·Helena HarderLesley J Fallowfield
Nov 30, 2019·Current Oncology Reports·Alexandra S Zimmer, Neelima Denduluri
Sep 11, 2020·Journal of breast cancer·Xinyan LiYingying Xu
Sep 30, 2020·Journal of Clinical Pharmacology·Ariel R Topletz-EricksonChristopher J Endres
Mar 9, 2021·Clinical Breast Cancer·Christian JackischHope S Rugo
Apr 3, 2021·Frontiers in Oncology·Chi Wah WongYuan Yuan
May 11, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Diana LüftnerNadia Harbeck
Jun 1, 2021·Oncology and Therapy·Michael UntchJoseph Gligorov
Jun 22, 2021·Frontiers in Medicine·Yingcheng WangPingyu Chen
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Thidarath RattanabureePotchanapond Graidist
Aug 21, 2021·Bioorganic & Medicinal Chemistry·Thais Cristina Mendonça Nogueira, Marcus Vinicius Nora de Souza
Nov 21, 2021·Oncology and Therapy·Megan L KruseChristopher T Stokoe